About 3 results found for searched term "LCZ696" (0.125 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M5731 | LCZ696 | Angiotensin Receptor |
| Sacubitril/Valsartan；Entresto | ||
| LCZ696, consisting of Valsartan and Sacubitril in a 1:1 molar ratio, is a first-in-class dual-action angiotensin receptor-neprilysin inhibitor (ARNi,angiotensin receptor-neprilysin inhibitor) for the study of hypertension and heart failure. | ||
| M6173 | AHU-377 hemicalcium salt | Neprilysin (NEP) |
| Sacubitril hemicalcium salt | ||
| AHU-377 hemicalcium salt is a potent NEP inhibitor with an IC50 of 5 nM. AHU-377 is a component of the heart failure medicine LCZ696. | ||
| M14479 | Sacubitril | Neprilysin (NEP) |
| AHU-377 | ||
| Sacubitril (AHU-377) is a potent NEP inhibitor with an IC50 of 5 nM. Sacubitril (AHU-377) is a component of the heart failure medicine LCZ696. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
